help + privacy policy + contact us + links + home
 
About APhACareerse-CommunitiesMeetingsPublicationsJoin APhA
Pharmacy Practice  

APhA2010 Annual Meeting Washington DC

APhA CEO Blog

APhA 
Foundation


Print this page
›› OIG exclusions list: Sounding alarm for awareness – Stiff penalties can threaten affected parties
›› Voltaren Gel: First FDA-approved topical prescription treatment for osteoarthritis – Efficacy and safety of NSAID diclofenac sodium topical gel proven in patients suffering from osteoarthritis pain of the hands and knees.
›› Nilotinib approved for chronic myelogenous leukemia – Approval of nilotinib offers new hope for patients with chronic myeloid leukemia resistant or intolerant to other therapies.
›› FDA approves rotigotine patches for Parkinson’s disease – Dopamine agonist provides additional option in patients with early disease.

›› A Pharmacist's Guide to Pandemic Preparedness - The foundation of response to a pandemic is a basic understanding of emergency preparedness plans and response systems, medication and health care delivery systems, access issues and the roles of pharmacists and support staff.

›› Project Destiny Executive Summary - The stated objective of Project Destiny is to develop a replicable, scalable, measurable, and economically viable future model for community pharmacy.  To that end, BearingPoint conducted extensive research and interviews with patient and provider groups, and private and public payers. 

›› Community Pharmacy Residency Program Training - Are you ready to build on your pharmacy education foundation, increase your knowledge, define a scope of your practice, and become experienced in direct patient care.

›› APhA's new preceptor center - A wealth of tools and information available here will make you a better preceptor!

›› APhA Career Pathway Program - Looking to make a change? Explore your options here.

›› MTM Central - Comprehensive information on developing patient care services, including medication therapy management services